Replicate Bioscience Announces Positive Initial Clinical Results for its Next Generation srRNA Technology

SAN DIEGO, Feb. 14, 2024. Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology to expand applications of RNA vaccines and other treatments, today shared positive results from the Phase 1 trial of...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials